GSVSX
Price
$15.62
Change
-$0.42 (-2.62%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

GSVSX vs RMFCX

Header iconGSVSX vs RMFCX Comparison
Open Charts GSVSX vs RMFCXBanner chart's image
Goldman Sachs Large Cap Value Svc
Price$15.62
Change-$0.42 (-2.62%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
GSVSX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSVSX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSVSX is a StrongBuy and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. GSVSX (446M). RMFCX pays higher dividends than GSVSX: RMFCX (1.69) vs GSVSX (0.82). GSVSX was incepted earlier than RMFCX: GSVSX (25 years) vs RMFCX (23 years). GSVSX is a more actively managed with annual turnover of: 57.00 vs. RMFCX (25.00). GSVSX has a lower initial minimum investment than RMFCX: GSVSX (0) vs RMFCX (250). GSVSX (9.76) and RMFCX (9.39) have marching annual gain over last year. RMFCX return over 5 years is better than : 36.51 vs. GSVSX (12.08).
GSVSXRMFCXGSVSX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years23 years-
Gain YTD8.1568.89692%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets446M98.7B0%
Annual Yield % from dividends0.821.6949%
Returns for 1 year9.769.39104%
Returns for 3 years3.5011.5730%
Returns for 5 years12.0836.5133%
Returns for 10 years-0.5858.17-1%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.850.02
+2.57%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc